ロード中...
Mifepristone for Treatment of Metabolic Syndrome: Beyond Cushing’s Syndrome
A growing body of research indicates that cortisol, the glucocorticoid product of the activation of the hypothalamic-pituitary-adrenal axis, plays a role in the pathophysiology of metabolic syndrome. In this regard, chronic exposure to cortisol is associated with risk factors related to metabolic sy...
保存先:
| 出版年: | Front Pharmacol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7193078/ https://ncbi.nlm.nih.gov/pubmed/32390830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00429 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|